Cargando…
Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer
The optimal treatment paradigm for patients with oligometastatic non-small cell lung cancer (NSCLC) remains unclear. Some patients with oligometastatic disease experience prolonged remission after locally consolidative radiation therapy (RT), while others harbor micrometastatic disease (below limits...
Autores principales: | Semenkovich, Nicholas P., Badiyan, Shahed N., Samson, Pamela P., Stowe, Hayley B., Wang, Yun E., Star, Rachel, Devarakonda, Siddhartha, Govindan, Ramaswamy, Waqar, Saiama N., Robinson, Clifford G., Vlacich, Gregory, Pellini, Bruna, Chaudhuri, Aadel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545784/ https://www.ncbi.nlm.nih.gov/pubmed/37783809 http://dx.doi.org/10.1038/s41698-023-00440-6 |
Ejemplares similares
-
Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer
por: Semenkovich, Nicholas P., et al.
Publicado: (2023) -
A phase II study of everolimus in patients with advanced solid malignancies with TSC1, TSC2, NF1, NF2 or STK11 mutations
por: Devarakonda, Siddhartha, et al.
Publicado: (2021) -
Untangling the evolutionary roots of lung cancer
por: Devarakonda, Siddhartha, et al.
Publicado: (2019) -
Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA
por: Semenkovich, Nicholas P, et al.
Publicado: (2023) -
Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung Cancer
por: Knapp, Brendan, et al.
Publicado: (2022)